Remimazolam Besylate in Mechanically Ventilated ICU Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Critical Illness
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
This is a randomized, open-label, small sample study using remimazolam and propofol for sedation in mechanically ventilated ICU patients. Subjects are randomized to different treatment groups (including 1 for Remimazolam Besylate and 1 for propofol). Remifentanil is co-administered with remimazolam ...
This is a randomized, open-label, small sample study using remimazolam and propofol for sedation in mechanically ventilated ICU patients. Subjects are randomized to different treatment groups (including 1 for Remimazolam Besylate and 1 for propofol). Remifentanil is co-administered with remimazolam or propofol. Efficacy and safety profiles of Remimazolam Besylate are to be evaluated.
Tracking Information
- NCT #
- NCT04790734
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: You Shang, Professor ICU, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Get Well Soon